JF
GTHX

Jump Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Jump Financial’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-34,400
Closed -$105K – 2398
2023
Q4 		$105K Buy
+34,400
New +$64.6K ﹤0.01% 1663
2023
Q3 		– Sell
-105,385
Closed -$262K – 2349
2023
Q2 		$262K Buy
+105,385
New +$288K 0.01% 1383
2023
Q1 		– Sell
-44,603
Closed -$242K – 2146
2022
Q4 		$242K Buy
44,603
+5,103
+13% +$42.8K 0.01% 1173
2022
Q3 		$493K Sell
39,500
-1,554
-4% -$17.8K 0.02% 909
2022
Q2 		$203K Buy
+41,054
New +$227K 0.01% 1308
2022
Q1 		– Sell
-19,400
Closed -$198K – 1994
2021
Q4 		$198K Buy
+19,400
New +$247K 0.01% 1121
2021
Q3 		– Sell
-33,902
Closed -$744K – 1590
2021
Q2 		$744K Buy
+33,902
New +$753K 0.07% 348
2020
Q4 		– Sell
-31,124
Closed -$359K – 1225
2020
Q3 		$359K Buy
+31,124
New +$514K 0.07% 433

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jump Financial's GTHX Position: Q1 2024 in Review

Jump Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 34,400 shares — an estimated $105K sold.

Jump Financial first reported a position in GTHX in Q3 2020 and held it in 8 quarters. The position peaked at $744K in Q2 2021. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

  • Jump Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jump Financial sold 34,400 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $105K.
  • Jump Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Jump Financial's G1 Therapeutics, Inc. Common Stock position peaked at $744K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jump Financial's 13F filing for Q1 2024, filed 13 May 2024.